Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'EOSINOPHILIA-MYALGIA SYNDROME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 196 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stahl, JL; Cook, EB; Pariza, MA; Cook, ME; Graziano, FM
      Effect of L-tryptophan supplementation on eosinophils and eotaxin in guinea pigs

      EXPERIMENTAL BIOLOGY AND MEDICINE
    2. Diggle, GE
      The toxic oil syndrome: 20 years on

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    3. Goodyear-Smith, F
      Health and safety issues pertaining to genetically modified foods

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
    4. Bujons, J; Ladona, MG; Messeguer, A; Morato, A; Ampurdanes, C
      Metabolism of (R)- and (S)-3-(phenylamino)propane-1,2-diol in C57BL/6-and A/J-strain mice. Identification of new metabolites with potential toxicological significance to the Toxic Oil Syndrome

      CHEMICAL RESEARCH IN TOXICOLOGY
    5. Novatchev, N; Holzgrabe, U
      Evaluation of the impurity profile of amino acids by means of CE

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    6. Kwon, SU; Kim, JC; Kim, JS
      Sequential magnetic resonance imaging findings in hypereosinophilia-induced encephalopathy

      JOURNAL OF NEUROLOGY
    7. Cowper, SE; Su, LD; Bhawan, J; Robin, HS; LeBoit, PE
      Nephrogenic fibrosing dermopathy

      AMERICAN JOURNAL OF DERMATOPATHOLOGY
    8. Rongioletti, F; Rebora, A
      Cutaneous mucinoses - Microscopic criteria for diagnosis

      AMERICAN JOURNAL OF DERMATOPATHOLOGY
    9. Maubec, E; Oberlin, O; Belhadj, K; Roujeau, JC
      Subcutaneous inflammatory edema induced by MINE chemotherapy

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    10. Closa, D; Folch, E; Calaf, RE; Abian, J; Rosello-Catafau, J; Gelpi, E
      Absorption and effects of 3-(N-phenylamino)-1,2-Propanediol esters in relation to Toxic Oil Syndrome

      LIPIDS
    11. Calaf, RE; Pena, J; Paytubi, S; Carrascal, M; Posada, M; Gelpi, E
      Automated strong cation exchange extraction of fatty acid esters of 3-(N-phenylamino)-1,2-propanediol from oil samples for routine quantification by HPLC-APCI/MS/MS

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    12. Calaf, RE; Pena, J; Paytubi, S; Blount, BC; de la Paz, MP; Gelpi, E; Abian, J
      Determination of aniline derivatives in oils related to the toxic oil syndrome by atmospheric pressure ionization-tandem mass spectrometry

      ANALYTICAL CHEMISTRY
    13. Levitan, RD; Shen, JH; Jindal, R; Driver, HS; Kennedy, SH; Shapiro, CM
      Preliminary randomized double-blind placebo-controlled trial of tryptophancombined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    14. Yoshida, SH
      The safety of genetically modified soybeans: Evidence and regulation

      FOOD AND DRUG LAW JOURNAL
    15. Nietert, PJ; Silver, RM
      Systemic sclerosis: environmental and occupational risk factors

      CURRENT OPINION IN RHEUMATOLOGY
    16. Posada, M; Gelpi, E
      Foreword

      HUMAN & EXPERIMENTAL TOXICOLOGY
    17. Egermayer, P
      Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?

      JOURNAL OF INTERNAL MEDICINE
    18. Hepburn, A; Coady, A; Livingstone, J; Pandit, N
      Eosinophilic cholecystitis as a possible late manifestation of the eosinophilia-myalgia syndrome

      CLINICAL RHEUMATOLOGY
    19. Cherin, P; Laforet, P; Gherardi, RK; Authier, FJ; Maisonobe, T; Coquet, M; Mussini, JM; Pellissier, JF; Eymard, B; Herson, S
      Macrophagic myofasciitis

      PRESSE MEDICALE
    20. Wald, JJ
      The effects of toxins on muscle

      NEUROLOGIC CLINICS
    21. D'Cruz, D
      Autoimmune diseases associated with drugs, chemicals and environmental factors

      TOXICOLOGY LETTERS
    22. Rubenstein, E
      Biologic effects of and clinical disorders caused by nonprotein amino acids

      MEDICINE
    23. Miller, FW; Hess, EV; Clauw, DJ; Hertzman, PA; Pincus, T; Silver, RM; Mayes, MD; Varga, J; Medsger, TA; Love, LA
      Approaches for identifying and defining environmentally associated rheumatic disorders

      ARTHRITIS AND RHEUMATISM
    24. Moore, DP; Kowalske, KJ
      Neuromuscular rehabilitation and electrodiagnosis. 5. Myopathy

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    25. Fernstrom, JD
      Can nutrient supplements modify brain function?

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    26. Adachi, J; Asano, M; Ueno, Y
      Tetrahydro-beta-carboline-3-carboxylic acids and contaminants of L-tryptophan

      JOURNAL OF CHROMATOGRAPHY A
    27. Harbuz, MS
      Chronic inflammatory stress

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    28. Branton, MH; Kopp, JB
      TGF-beta and fibrosis

      MICROBES AND INFECTION
    29. Veasey, SC; Fenik, P; Panckeri, K; Pack, AI; Hendricks, JC
      The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    30. Ladona, MG; Bujons, J; Messeguer, A; Ampurdanes, C; Morato, A; Corbella, J
      Biotransformation and clearance of 3-(Phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice

      CHEMICAL RESEARCH IN TOXICOLOGY
    31. Abenhaim, L; Humbert, M
      Pulmonary hypertension related to drugs and toxins

      CURRENT OPINION IN CARDIOLOGY
    32. Cherin, P; Laforet, P; Gherardi, RK; Authier, FJ; Coquet, M; Maisonobe, T; Mussini, JM; Pellissier, JF; Herson, S
      Macrophagic myofasciitis: description and hypotheses

      REVUE DE MEDECINE INTERNE
    33. Mellor, AL; Munn, DH
      Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

      IMMUNOLOGY TODAY
    34. Connolly, HM; McGoon, MD
      Obesity drugs and the heart

      CURRENT PROBLEMS IN CARDIOLOGY
    35. Cooper, GS; Miller, FW; Pandey, JP
      The role of genetic factors in autoimmune disease: Implications for environmental research

      ENVIRONMENTAL HEALTH PERSPECTIVES
    36. Ligier, S; Sternberg, EM
      Neuroendocrine host factors and inflammatory disease susceptibility

      ENVIRONMENTAL HEALTH PERSPECTIVES
    37. Bell, SA; Page, S; Baumgartner, B; Berking, C; Haas, M; Eisele, T; Neumeier, D; Brand, K
      Involvement of nuclear factor-kappa B in a murine model for the acute formof autoimmune-like toxic oil syndrome

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    38. Fugh-Berman, A; Cott, JM
      Dietary supplements and natural products as psychotherapeutic agents

      PSYCHOSOMATIC MEDICINE
    39. Hensrud, DD
      Nutrition screening and assessment

      MEDICAL CLINICS OF NORTH AMERICA
    40. Naylor, S; Gleich, GJ
      Silent but widespread use of dietary supplements

      MAYO CLINIC PROCEEDINGS
    41. Hensrud, DD; Engle, DD; Scheitel, SM
      Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination

      MAYO CLINIC PROCEEDINGS
    42. Fishman, AP
      Aminorex to fen/phen - An epidemic foretold

      CIRCULATION
    43. Steinberg, S; Annable, L; Young, SN; Liyanage, N
      A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria

      BIOLOGICAL PSYCHIATRY
    44. COLUCCI RA; GOODRUM KJ
      LACK OF INTERLEUKIN-5 PRODUCTION BY T-LYMPHOCYTES ISOLATED FROM FIBROMYALGIA PATIENTS AND NORMAL CONTROLS AFTER BEING CULTURED WITH 1,1'-ETHYLIDENEBIS TRYPTOPHAN, A SUSPECTED CAUSAL CONTAMINANT OF EOSINOPHILIA-MYALGIA-SYNDROME

      Journal of musculoskeletal pain
    45. Bohme, A; Wolter, M; Hoelzer, D
      L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia

      ANNALS OF HEMATOLOGY
    46. MASSEY KA; BLAKESLEE CH; PITKOW HS
      A REVIEW OF PHYSIOLOGICAL AND METABOLIC EFFECTS OF ESSENTIAL AMINO-ACIDS

      Amino acids
    47. MORIGUCHI M; TERAI C; KUROKI S; TANAKA E; SOMEYA N; TSUNODA Y; KASHIWAZAKI S
      EOSINOPHILIC FASCIITIS COMPLICATED WITH PERIPHERAL POLYNEUROPATHY

      Internal medicine
    48. VODERHOLZER U; HORNYAK M; THIEL B; HUWIGPOPPE C; KIEMEN A; KONIG A; BACKHAUS J; RIEMANN D; BERGER M; HOHAGEN F
      IMPACT OF EXPERIMENTALLY-INDUCED SEROTONIN DEFICIENCY BY TRYPTOPHAN DEPLETION ON SLEEP EEG IN HEALTHY-SUBJECTS

      Neuropsychopharmacology
    49. HAUSTEIN UF; HAUPT B
      DRUG-INDUCED SCLERODERMA AND SCHLERODERMIFORM CONDITIONS

      Clinics in dermatology
    50. NOLTE H; HELMCHEN U
      2 CLINICAL CASES CONCERNING THE SPECTRUM OF HYPEREOSINOPHILIC SYNDROME

      Medizinische Klinik
    51. WILLIAMSON BL; JOHNSON KL; TOMLINSON AJ; GLEICH GJ; NAYLOR S
      ONLINE HPLC TANDEM MASS-SPECTROMETRY STRUCTURAL CHARACTERIZATION OF CASE-ASSOCIATED CONTAMINANTS OF L-TRYPTOPHAN IMPLICATED WITH THE ONSET OF EOSINOPHILIA-MYALGIA-SYNDROME

      Toxicology letters
    52. JORGENSEN KM; WITTING MD
      DOES EXOGENOUS MELATONIN IMPROVE DAY SLEEP OR NIGHT ALERTNESS IN EMERGENT PHYSICIANS WORKING NIGHT SHIFTS

      Annals of emergency medicine
    53. LLEWELLYN LJ; EVANS MR; PALMER SR
      USE OF SEQUENTIAL CASE-CONTROL STUDIES TO INVESTIGATE A COMMUNITY SALMONELLA OUTBREAK IN WALES

      Journal of epidemiology and community health
    54. PARCHMENT RE
      ALTERNATIVE TESTING SYSTEMS FOR EVALUATING NONCARCINOGENIC, HEMATOLOGIC TOXICITY

      Environmental health perspectives
    55. BHATTI T; GILLIN JC; SEIFRITZ E; MOORE P; CLARK C; GOLSHAN S; STAHL S; RAPAPORT M; KELSOE J
      EFFECTS OF A TRYPTOPHAN-FREE AMINO-ACID DRINK CHALLENGE ON NORMAL HUMAN SLEEP ELECTROENCEPHALOGRAM AND MOOD

      Biological psychiatry
    56. HERDERICH M; GUTSCHE B
      TRYPTOPHAN-DERIVED BIOACTIVE COMPOUNDS IN FOOD

      Food reviews international
    57. HITRAYA EG; JIMENEZ SA; LUDWICKA A; SILVER RM; VARGA J
      INCREASED ACTIVITY OF THE ALPHA-1(I) PROCOLLAGEN PROMOTER IN SKIN FIBROBLASTS FROM PATIENTS WITH CHRONIC EOSINOPHILIA-MYALGIA-SYNDROME

      International journal of biochemistry & cell biology
    58. SIDRANSKY H
      DIETARY TRYPTOPHAN AND AGING

      Amino acids
    59. MARTINEZ JL; BEHRENS MM; MORATILLA C; RENART J
      OLEOYLANILIDE, A POSSIBLE CAUSATIVE AGENT OF TOXIC OIL SYNDROME, INTERFERES WITH THE CYTOSKELETON IN A NEURONAL CELL-LINE

      Neurotoxicology and teratology
    60. SIMAT T; STEINHART H
      USE OF TRYPTOPHANASE IN THE DETECTION OF CONTAMINANTS IN EMS RELATED L-TRYPTOPHAN

      Journal of pharmaceutical and biomedical analysis
    61. WILLIAMSON BL; BENSON LM; TOMLINSON AJ; MAYENO AN; GLEICH GJ; NAYLOR S
      ONLINE HPLC TANDEM MASS-SPECTROMETRY ANALYSIS OF CONTAMINANTS OF L-TRYPTOPHAN ASSOCIATED WITH THE ONSET OF THE EOSINOPHILIA-MYALGIA-SYNDROME

      Toxicology letters
    62. HEISKANEN KM; SAVOLAINEN KM
      EFFECTS OF 3-PHENYLAMINO-1,2-PROPANEDIOL AND ITS MONO-OLEYLESTER AND DIOLEYLESTER ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES IN HUMANPOLYMORPHONUCLEAR LEUKOCYTES

      Toxicology letters
    63. HEISKANEN KM; MUNZING S; KROMBACH F; SAVOLAINEN KM
      EFFECT OF LINOLEIC-ACID, LINOLEIC-ACID ANILIDE, AND ARACHIDONIC-ACID ON THE EXPRESSION OF ADHESION MOLECULES ON HUMAN NEUTROPHILS

      Archives of toxicology
    64. CARREIRA PE; MONTALVO MG; KAUFMAN LD; SILVER RM; IZQUIERDO M; GOMEZREINO JJ
      ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH EOSINOPHILIA MYALGIA ANDTOXIC OIL SYNDROME

      Journal of rheumatology
    65. PETERSON LS; NELSON AM; SU WPD; MASON T; OFALLON WM; GABRIEL SE
      THE EPIDEMIOLOGY OF MORPHEA (LOCALIZED SCLERODERMA) IN OLMSTED COUNTY1960-1993

      Journal of rheumatology
    66. FURST DE; CLEMENTS PJ
      HYPOTHESIS FOR THE PATHOGENESIS OF SYSTEMIC-SCLEROSIS

      Journal of rheumatology
    67. SIDRANSKY H; VERNEY E
      MOUSE STRAIN AND SOURCE OF L-TRYPTOPHAN AFFECTS HEPATIC NUCLEAR TRYPTOPHAN BINDING

      Toxicology
    68. DELPOZO V; DEANDRES B; GALLARDO S; CARDABA B; DEARRUDACHAVES E; CORTEGANO MI; JURADO A; PALOMINO P; OLIVA H; AGUILERA B; POSADA M; LAHOZ C
      CYTOKINE MESSENGER-RNA EXPRESSION IN LUNG-TISSUE FROM TOXIC OIL SYNDROME PATIENTS - A TH2 IMMUNOLOGICAL MECHANISM

      Toxicology
    69. GALLARDO S; CARDABA B; DELPOZO V; DEANDRES B; CORTEGANO I; JURADO A; TRAMON P; PALOMINO P; LAHOZ C
      STUDY OF APOPTOSIS IN HUMAN-LYMPHOCYTES BY TOXIC-SUBSTANCES IMPLICATED IN TOXIC-OIL-SYNDROME

      Toxicology
    70. HALLE O; SCHAEVERBEKE T; BANNWARTH B; DEHAIS J
      ENVIRONMENTAL AND IATROGENIC FACTORS IN S YSTEMIC-SCLEROSIS AND RELATED CONDITIONS - REVIEW OF THE LITERATURE

      La Revue de medecine interne
    71. SIDRANSKY H
      TRYPTOPHAN AND CARCINOGENESIS - REVIEW AND UPDATE ON HOW TRYPTOPHAN MAY ACT

      Nutrition and cancer
    72. MCDOUGLE CJ
      UPDATE ON PHARMACOLOGICAL MANAGEMENT OF OCD - AGENTS AND AUGMENTATION

      The Journal of clinical psychiatry
    73. KRANKE B; ABERER W
      MACROLIDE-INDUCED CHURG-STRAUSS-SYNDROME IN PATIENT WITH ATOPY

      Lancet
    74. HUBNER C; DIETZ A; STREMMEL W; STIEHL A; ANDRASSY K
      MACROLIDE-INDUCED CHURG-STRAUSS-SYNDROME IN PATIENT WITH ATOPY - REPLY

      Lancet
    75. STERNBERG EM
      INTIMIDATION OF RESEARCHERS BY SPECIAL-INTEREST GROUPS

      The New England journal of medicine
    76. PESTANA A
      15 YEARS OF RESEARCH ON THE TOXIC OIL SYN DROME

      Medicina Clinica
    77. MITCHELL H; BOLSTER MB; LEROY EC
      SCLERODERMA AND RELATED CONDITIONS

      The Medical clinics of North America
    78. WILLIAMSON BL; TOMLINSON AJ; NAYLOR S; GLEICH GJ
      CONTAMINANTS IN COMMERCIAL PREPARATIONS OF MELATONIN

      Mayo Clinic proceedings
    79. ARMSTRONG C; LEWIS T; DESPOSITO M; FREUNDLICH B
      EOSINOPHILIA-MYALGIA-SYNDROME - SELECTIVE COGNITIVE IMPAIRMENT, LONGITUDINAL EFFECTS, AND NEUROIMAGING FINDINGS

      Journal of Neurology, Neurosurgery and Psychiatry
    80. DICKINSON CJ
      CHRONIC FATIGUE SYNDROME - ETIOLOGIC ASPECTS

      European journal of clinical investigation
    81. STEINHART H; BIERNOTH G
      CAN FOOD QUALITY BE ENHANCED BY CHROMATOGRAPHY

      Chromatographia
    82. EISENBERG DM
      ADVISING PATIENTS WHO SEEK ALTERNATIVE MEDICAL THERAPIES

      Annals of internal medicine
    83. HERRAIZ T; SANCHEZ F
      PRESENCE OF TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACIDS IN FOODS BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY AS THEIR N-METHOXYCARBONYL METHYL-ESTER DERIVATIVES

      Journal of chromatography
    84. SIMAT T; VANWICKERN B; EULITZ K; STEINHART H
      CONTAMINANTS IN BIOTECHNOLOGICALLY MANUFACTURED L-TRYPTOPHAN

      Journal of chromatography B. Biomedical applications
    85. LAZARUS NR
      POPULATION HETEROGENEITY AND ITS IMPACT ON THE RISK MANAGEMENT OF FOOD SAFETY

      Environmental toxicology and pharmacology
    86. YOUNG SN
      MELATONIN, SLEEP, AGING, AND THE HEALTH PROTECTION BRANCH

      Journal of psychiatry & neuroscience
    87. TSUTSUI K; TANIUCHI K; MORI T; TAKEHARA K
      EOSINOPHILIO-MYALGIA SYNDROME - A REPORT OF 2 CASES IN JAPAN

      EJD. European journal of dermatology
    88. SUZUKI S; TOURKINA E; LUDWICKA A; HAMPTON M; BOLSTER M; MAIZE J; SILVER R
      A CONTAMINANT OF L-TRYPTOPHAN ENHANCES EXPRESSION OF DERMAL COLLAGEN IN A MURINE MODEL OF EOSINOPHILIA-MYALGIA-SYNDROME

      Proceedings of the Association of American Physicians
    89. SAINIO EL; PULKKI K; YOUNG SN
      L-TRYPTOPHAN - BIOCHEMICAL, NUTRITIONAL AND PHARMACOLOGICAL ASPECTS

      Amino acids
    90. PARKE AL; PARKE DV; JONES FA
      DIET AND NUTRITION IN RHEUMATOID-ARTHRITIS AND OTHER CHRONIC INFLAMMATORY DISEASES

      Journal of clinical biochemistry and nutrition
    91. MURRAY R; RUFF RM
      COGNITIVE, EMOTIONAL, AND PHYSICAL DEFICITS ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME

      Neuropsychiatry, neuropsychology, and behavioral neurology
    92. SCHURZ HH; HILL RH; DELAPAZ MP; PHILEN RM; BORDA IA; BAILEY SL; NEEDHAM LL
      PRODUCTS OF ANILINE AND TRIGLYCERIDES IN OIL SAMPLES ASSOCIATED WITH THE TOXIC OIL SYNDROME

      Chemical research in toxicology
    93. MIDDAUGH LD; NUSSBAUM R; LUDWICKA A; BOLSTER MB; SILVER RM
      COGNITIVE DEFICITS IN A MURINE MODEL OF THE EOSINOPHILIA-MYALGIA-SYNDROME - A PRELIMINARY-REPORT

      Neurotoxicology and teratology
    94. BUSS WC; STEPANEK J; BANKHURST AD; MAYENO AN; PASTUSZYN A; PEABODY D
      EBT, A TRYPTOPHAN CONTAMINANT ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME, IS INCORPORATED INTO PROTEINS DURING TRANSLATION AS AN AMINO-ACID ANALOG

      Autoimmunity
    95. FOUCHER P; BIOUR M; GODARD P; OLLAGNIER M; MAYAUD C; CAMUS P; BLAYAC JP; DALPHIN JC; KUHN M; PFITZENMEYER P; SGRO C; VALEYRE D; VERVLOET D; VERGNON JM
      IATROGENIC PULMONARY-DISEASES INDUCED BY CHEMOTHERAPY

      Revue des maladies respiratoires
    96. RYAN AS; GOLDSMITH LA
      NUTRITION AND THE SKIN

      Clinics in dermatology
    97. SPYKER D; LOVE LA; BROOKS SM
      AN OUTBREAK OF PULMONARY POISONING - EDITORIAL COMMENT

      Journal of toxicology. Clinical toxicology
    98. WAGNER KR; ELMORE JG; HORWITZ RI
      DIAGNOSTIC BIAS IN CLINICAL DECISION-MAKING - AN EXAMPLE OF L-TRYPTOPHAN AND THE DIAGNOSIS OF EOSINOPHILIA-MYALGIA-SYNDROME

      Journal of rheumatology
    99. SULLIVAN EA; STAEHLING N; PHILEN RM
      EOSINOPHILIA-MYALGIA-SYNDROME AMONG THE NON-L-TRYPTOPHAN USERS AND PRE-EPIDEMIC CASES

      Journal of rheumatology
    100. HERTZMAN PA
      CRITERIA FOR THE DEFINITION OF THE EOSINOPHILIA-MYALGIA-SYNDROME

      Journal of rheumatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 23:00:32